Elicio Therapeutics, Inc. (ELTX) News
Track canonical SquawkNews coverage tagged to ELTX, Elicio Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Elicio Therapeutics reports Q2 2026 financial results, provides corporate updates
Elicio Therapeutics (ELTX) reports its second-quarter 2026 financial results and provides corporate updates, according to the TradeXchange Newsdesk.
EARNINGS | Aug 13, 2026, 08:01 PM UTC
H
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Liminatus Pharma (NASDAQ: LIMN ) stock increased by 40.9% to $0.16 during Thursday's pre-market session. The market value of their outstanding shares is at $5.8 million. Stablecoin Development (AMEX: SDEV ) stock
EARNINGS | Jul 02, 2026, 12:05 PM UTC
L
Elicio Therapeutics shares are trading lower after the company announced the pricing of its $15 million offering of 4,380,313 shares.
Elicio Therapeutics shares are trading lower after the company announced the pricing of its $15 million offering of 4,380,313 shares.
EQUITY | Jul 02, 2026, 11:52 AM UTC
L
Elicio Therapeutics Prices $15M Registered Direct Offering Of 4,380,313 Common Shares, Proceeds To Fund Phase 1 Development Of ELI-002 7P In
Elicio Therapeutics Prices $15M Registered Direct Offering Of 4,380,313 Common Shares, Proceeds To Fund Phase 1 Development Of ELI-002 7P In Metastatic PDAC
EQUITY | Jul 02, 2026, 06:26 AM UTC